Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
10 auth.
M. Dominici,
K. Blanc,
Ingo Mueller,
I. Slaper-Cortenbach,
F. Marini,
D. Krause,
...
R. Deans,
A. Keating,
D. Prockop,
E. Horwitz
|
13 |
2006 |
13
2006
|
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.
9 auth.
E. Horwitz,
K. Blanc,
M. Dominici,
Ingo Mueller,
I. Slaper-Cortenbach,
F. Marini,
...
R. Deans,
D. Krause,
A. Keating
|
10 |
2005 |
10
2005
|
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT).
10 auth.
P. Bourin,
B. Bunnell,
L. Casteilla,
M. Dominici,
A. Katz,
K. March,
...
H. Redl,
J. P. Rubin,
K. Yoshimura,
J. Gimble
|
10 |
2013 |
10
2013
|
Adipose-derived adult stem cells: isolation, characterization, and differentiation potential.
J. Gimble,
F. Guilak
|
10 |
2003 |
10
2003
|
Yield of human adipose-derived adult stem cells from liposuction aspirates.
9 auth.
L. Aust,
B. Devlin,
S. Foster,
Y. Halvorsen,
K. Hicok,
T. D. Laney,
...
A. Sen,
G. D. Willingmyre,
J. Gimble
|
9 |
2004 |
9
2004
|
Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature.
10 auth.
S. Viswanathan,
Yufang Shi,
Yufang Shi,
J. Galipeau,
M. Krampera,
K. Leblanc,
...
I. Martin,
J. Nolta,
D. Phinney,
L. Sensébé
|
9 |
2019 |
9
2019
|
Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure.
8 auth.
Maikel J. Oedayrajsingh-Varma,
S. M. V. Ham,
M. Knippenberg,
M. Helder,
J. Klein-Nulend,
T. Schouten,
...
M. Ritt,
F. V. Milligen
|
8 |
2006 |
8
2006
|
The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
J. Galipeau
|
8 |
2013 |
8
2013
|
Treatment of patients with advanced cancer with the natural killer cell line NK-92.
10 auth.
T. Tonn,
D. Schwabe,
H. Klingemann,
S. Becker,
R. Esser,
U. Koehl,
...
M. Suttorp,
E. Seifried,
O. Ottmann,
G. Bug
|
8 |
2013 |
8
2013
|
Mesenchymal stem cells: progress toward promise.
K. Le Blanc,
Mf Pittenger
|
8 |
2005 |
8
2005
|
Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.
M. Krampera,
J. Galipeau,
Yufang Shi,
K. Tarte,
L. Sensébé
|
8 |
2013 |
8
2013
|
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.
14 auth.
M. Geller,
S. Cooley,
P. Judson,
R. Ghebre,
L. Carson,
P. Argenta,
A. L. Jonson,
A. Panoskaltsis‐Mortari,
J. Curtsinger,
D. McKenna,
...
K. Dusenbery,
R. Bliss,
L. Downs,
Jeffrey S. Miller
|
8 |
2011 |
8
2011
|
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.
25 auth.
J. Galipeau,
M. Krampera,
J. Barrett,
F. Dazzi,
R. Deans,
Joost DeBruijn,
M. Dominici,
W. Fibbe,
A. Gee,
J. Gimble,
P. Hematti,
M. Koh,
K. Leblanc,
I. Martin,
I. Mcniece,
...
M. Mendicino,
Steve Oh,
L. Ortiz,
D. Phinney,
V. Planat,
Yufang Shi,
D. Stroncek,
S. Viswanathan,
D. Weiss,
L. Sensébé
|
8 |
2016 |
8
2016
|
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial.
7 auth.
S. Arai,
R. Meagher,
M. Swearingen,
H. Myint,
E. Rich,
J. Martinson,
...
H. Klingemann
|
8 |
2008 |
8
2008
|
Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.
J. Kode,
S. Mukherjee,
M. Joglekar,
A. Hardikar
|
8 |
2009 |
8
2009
|
The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration.
V. B. R. Konala,
M. K. Mamidi,
R. Bhonde,
A. Das,
R. Pochampally,
Rajarshi Pal
|
8 |
2016 |
8
2016
|
